Publications by authors named "Mayte Gil-Candel"

Claim this Profile
V
Validation of pharmacokinetic model for quizartinib quantified by UPLC-MS/MS in patients with FLT3-ITD negative newly diagnosed acute myeloid leukemia.
Antonio Solana-Altabella, Carles Iniesta-Navalón, Maria Chovi-Trull, Rebeca Rodriguez-Veiga, Marina Lopez-Nogueroles, Mayte Gil-Candel

Eur J Clin Pharmacol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimisation of voriconazole treatment in paediatric patients with fungal endocarditis: a pharmacokinetics case report.
Mario Rodenas-Rovira, Mayte Gil-Candel, Inés Burgos-Berjillos, Catalina Montoya-Tamayo, Javier Garcia-Pellicer

Eur J Hosp Pharm· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A collaborative telepharmacy model for dispensing and informed delivery from hospital to community pharmacies.
Esther Vicente-Escrig, Antonio Solana-Altabella, Maria José Company-Albir, Mayte Gil-Candel, Raul Ferrando-Piqueres

Eur J Hosp Pharm· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetics in Response to Biological Agents in Inflammatory Bowel Disease: A Systematic Review.
Octavio Ballesta-López, Mayte Gil-Candel, María Centelles-Oria, Juan Eduardo Megías-Vericat, Antonio Solana-Altabella

Int J Mol Sci· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing a telepharmacy programme with home medication dispensing and informed delivery in a tertiary hospital: description of the model and analysis of the results.
Mayte Gil-Candel, Antonio Solana-Altabella, Esther Vicente-Escrig, Aarón Puplá-Bartoll, Julia Bodega Azuara

Eur J Hosp Pharm· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between ustekinumab trough concentrations and biochemical outcomes in patients with Crohn's disease. A real life study.
Rosa Gómez Espín, Isabel Nicolás De Prado, Mayte Gil Candel, Marta González Carrión, Lorena Rentero Redondo

Rev Esp Enferm Dig· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Usefulness of population pharmacokinetics to optimize the dosage regimen of infliximab in inflammatory bowel disease patients.
Mayte Gil Candel, Juan José Gascón Cánovas, Rosa Gómez Espín, Isabel Nicolás de Prado, Lorena Rentero Redondo

Rev Esp Enferm Dig· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Usefulness of therapeutic drug monitoring of infliximab during the induction period in patients with inflammatory bowel disease.
Mayte Gil Candel, Juan José Gascón Cánovas, Elena Urbieta Sanz, Rosa Gómez Espín, Isabel Nicolás de Prado

Rev Esp Enferm Dig· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of drug survival between infliximab and adalimumab in inflammatory bowel disease.
Mayte Gil-Candel, Juan José Gascón-Cánovas, Elena Urbieta-Sanz, Lorena Rentero-Redondo, María Onteniente-Candela

Int J Clin Pharm· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis